Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial

Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the clinical trial record page.
    Difference
    1%
    Check dated 2026-10-24T23:15:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T23:38:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T23:33:48.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study record content and navigation. This blocks access to the trial details and related information on the page.
    Difference
    19%
    Check dated 2026-09-19T22:18:59.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page shows a revision tag updated to v3.6.6, replacing the previous v3.6.5. This indicates a small version update with no apparent changes to the visible content or study information.
    Difference
    0.1%
    Check dated 2026-08-29T21:55:05.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, replacing Revision: v3.6.4. This indicates a small update to the study record on ClinicalTrials.gov without altering the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:45:29.000Z thumbnail image

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.